Patawee Asamaphan
Research Subjects
Patawee Asamaphan has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Emma C. Thomson
MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom
3 shared publications - Antonia Ho
Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow; Queen Elizabeth University Hospital, Glasgow
2 shared publications - Brian James Willett
MRC-University of Glasgow Centre for Virus Research
2 shared publications - Richard J. Orton
Affiliation MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Garscube Campus, Glasgow, United Kingdom
2 shared publications Alasdair MacLean
West of Scotland Specialist Virology Centre
1 shared publication- Ana da Silva Filipe
MRC–University of Glasgow Centre for Virus Research, Glasgow, UK
1 shared publication
Latest Publications
- Open Access
- 9 November 2023
- Published by Elsevier in The Lancet
- Vol. 402 (10417) , 2075-2076
Omicron BA.2.86 cross-neutralising activity in community sera from the UK
- 9 November 2023
- Published by Elsevier in The Lancet
- Vol. 402 (10417) , 2075-2076
Open AccessOmicron BA.2.86 cross-neutralising activity in community sera from the UK
- 12 May 2023
- Published by H1 Connect
Faculty Opinions recommendation of Heterogeneous plasma cells and long-lived subsets in response to immunization, autoantigen and microbiota.
Using single-cell mRNA sequencing, cytometry and genetic pulse, Xin et al. were able to identify markers that could be used to identify long-lived plasma cells that reside in mouse bone marrow. The findings will help in the identification of long-lived plasma cells in other vaccine studies specific to other pathogens.
- 12 May 2023
- Published by H1 Connect
Faculty Opinions recommendation of Heterogeneous plasma cells and long-lived subsets in response to immunization, autoantigen and microbiota.
Using single-cell mRNA sequencing, cytometry and genetic pulse, Xin et al. were able to identify markers that could be used to identify long-lived plasma cells that reside in mouse bone marrow. The findings will help in the identification of long-lived plasma cells in other vaccine studies specific to other pathogens.
- Open Access
Adeno-associated virus 2 infection in children with non-A-E hepatitis
Summary paragraph: An outbreak of acute hepatitis of unknown aetiology in children was first reported in Scotland in April 2022. 1 Cases aged 2 Here we report a detailed investigation of 9 early cases and 58 control subjects. Using next-generation sequencing and real-time PCR, adeno-associated virus 2 (AAV2), was detected in the plasma of 9/9 and liver of 4/4 patients but in 0/13 sera/plasma of age-matched healthy controls, 0/12 children with adenovirus (HAdV) infection and normal liver function and 0/33 children admitted to hospital with hepatitis of other aetiology. AAV2 typically requires a coinfecting ‘helper’ virus to replicate, usually HAdV or a herpesvirus. HAdV (species C and F) and human herpesvirus 6B (HHV6B) were detected in 6/9 and 3/9 affected cases, including 3/4 and 2/4 liver biopsies, respectively. The class II HLA-DRB1*04:01 allele was identified in 8/9 cases (89%), compared with a background frequency of 15.6% in Scottish blood donors, suggestive of increased susceptibility in affected cases. Acute non-A-E paediatric hepatitis is associated with the presence of AAV2 infection, which could represent a primary pathogen or a useful biomarker of recent HAdV or HHV6B infection. Population and mechanistic studies are required to explore these findings further.
Open AccessAdeno-associated virus 2 infection in children with non-A-E hepatitis
Summary paragraph: An outbreak of acute hepatitis of unknown aetiology in children was first reported in Scotland in April 2022. 1 Cases aged 2 Here we report a detailed investigation of 9 early cases and 58 control subjects. Using next-generation sequencing and real-time PCR, adeno-associated virus 2 (AAV2), was detected in the plasma of 9/9 and liver of 4/4 patients but in 0/13 sera/plasma of age-matched healthy controls, 0/12 children with adenovirus (HAdV) infection and normal liver function and 0/33 children admitted to hospital with hepatitis of other aetiology. AAV2 typically requires a coinfecting ‘helper’ virus to replicate, usually HAdV or a herpesvirus. HAdV (species C and F) and human herpesvirus 6B (HHV6B) were detected in 6/9 and 3/9 affected cases, including 3/4 and 2/4 liver biopsies, respectively. The class II HLA-DRB1*04:01 allele was identified in 8/9 cases (89%), compared with a background frequency of 15.6% in Scottish blood donors, suggestive of increased susceptibility in affected cases. Acute non-A-E paediatric hepatitis is associated with the presence of AAV2 infection, which could represent a primary pathogen or a useful biomarker of recent HAdV or HHV6B infection. Population and mechanistic studies are required to explore these findings further.